DRI Healthcare Trust (DHT.U) Buys Juvmo U.S. Royalties for $316M, Receipts Capped at $437.5M

DRI Healthcare Trust will pay $316M to acquire U.S. net sales royalty rights in Juvmo (tavapadon), following FDA approval. The deal includes four $23.4M fixed annual payments and tiered royalties, with aggregate receipts capped at $437.5M; closing expected Sept. 29, 2026.Material DetailsContext by…